Variant: rs3132580 

    present in Gene: HCG21;SFTA2;MUCL3
    present in Chromosome: 6
    Position on Chromosome: 30952347
    Alleles of this Variant: G/A

rs3132580 in HCG21;SFTA2;MUCL3 gene and Adenocarcinoma of lung (disorder) PMID 19836008 2009 A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Diabetes Mellitus, Insulin-Dependent PMID 17632545 2007 A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Lupus Erythematosus, Systemic PMID 24871463 2014 GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Malignant neoplasm of lung PMID 22899653 2012 Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Membranous glomerulonephritis PMID 21323541 2011 Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Myasthenia Gravis PMID 23055271 2012 Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

rs3132580 in HCG21;SFTA2;MUCL3 gene and Vitiligo PMID 20526339 2010 Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.